Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · IEX Real-Time Price · USD
46.61
-1.07 (-2.24%)
At close: Jul 19, 2024, 4:00 PM
45.68
-0.93 (-2.00%)
Pre-market: Jul 22, 2024, 6:18 AM EDT
Agios Pharmaceuticals Market Cap
Agios Pharmaceuticals has a market cap or net worth of $2.65 billion as of July 22, 2024. Its market cap has increased by 76.14% in one year.
Market Cap
2.65B
Enterprise Value
2.12B
1-Year Change
76.14%
Ranking
Category
Stock Price
$46.61
Market Cap Chart
Since July 24, 2013, Agios Pharmaceuticals's market cap has increased from $919.00M to $2.65B, an increase of 187.94%. That is a compound annual growth rate of 10.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 2.65B | 112.60% |
| Dec 29, 2023 | 1.24B | -19.33% |
| Dec 30, 2022 | 1.54B | -13.57% |
| Dec 31, 2021 | 1.79B | -40.52% |
| Dec 31, 2020 | 3.00B | 6.73% |
| Dec 31, 2019 | 2.81B | 4.81% |
| Dec 31, 2018 | 2.68B | -3.76% |
| Dec 29, 2017 | 2.79B | 58.97% |
| Dec 30, 2016 | 1.75B | -28.25% |
| Dec 31, 2015 | 2.44B | -37.12% |
| Dec 31, 2014 | 3.89B | 420.55% |
| Dec 31, 2013 | 746.50M | -18.77% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MoonLake Immunotherapeutics | 2.81B |
| SpringWorks Therapeutics | 2.79B |
| Bausch Health Companies | 2.79B |
| Apogee Therapeutics | 2.78B |
| Geron | 2.73B |
| Progyny | 2.65B |
| Kymera Therapeutics | 2.64B |
| Certara | 2.59B |